Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells. (Q47671726)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Vladimir Jurisic

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Gordana Konjević

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Katarina Mirjacić Martinović

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nada Babović

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ivan Spuzić

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

258-270

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK phenotypic markers and IL2 response in NK cells from elderly people.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Human natural killer cells

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK cells: new issues and challenges. Preface.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK cells: innate immunity against hematological malignancies?

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

The role of the NKG2D receptor for tumor immunity

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Human natural killer cell development and biology

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NKG2D and cytotoxic effector function in tumor immune surveillance

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Tolerance and reactivity of NK cells: two sides of the same coin?

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK cell receptors

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK cell recognition

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

NKG2D ligands in tumor immunity

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Immunogenetics of killer cell immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

MHC class I molecules and KIRs in human history, health and survival

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Self-tolerance of natural killer cells

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Roles of the NKG2D immunoreceptor and its ligands

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Mini-review: defense strategies and immunity-related genes

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Human diversity in killer cell inhibitory receptor genes

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Natural killer cell signaling pathways

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1080%2F13547500902814658

21 January 2018

Identifiers

10.1080/13547500902814658

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19489688%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47671726&oldid=1527863064"